Evidence map›Paper›PMID 27706161›Full record

ArticlePLoS neglected tropical diseases2016

Full Genome Sequence and sfRNA Interferon Antagonist Activity of Zika Virus from Recife, Brazil.

Claire L Donald, Benjamin Brennan, Stephanie L Cumberworth, Veronica V Rezelj, Jordan J Clark, Marli T Cordeiro, Rafael Freitas de Oliveira França, Lindomar J Pena, Gavin S Wilkie, Ana Da Silva Filipe and 15 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 145 papers.

0numbers the graph read from it
0cells of the map it votes in
145citing papers in PubMed
26.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

145 citing papers in PubMed, 248 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Cellular Biology: Virus-Host Interactions and RNA Structure and Function.Current topics in microbiology and immunology · 2026
    Review
  10. Article
  11. Y-box binding proteins in immunity and RNA virus infection.Microbiology and molecular biology reviews : MMBR · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

85 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 7 institutions in 5 countries.

Claire L DonaldMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Benjamin BrennanMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Stephanie L CumberworthMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Veronica V RezeljMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Jordan J ClarkMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Marli T CordeiroFundação Oswaldo Cruz-PE/Centro de Pesquisas Aggeu Magalhães, Departamento de Virologia, Campus da UFPE-Cidade Universitária, Recife/PE, Brasil.
Rafael Freitas de Oliveira FrançaFundação Oswaldo Cruz-PE/Centro de Pesquisas Aggeu Magalhães, Departamento de Virologia, Campus da UFPE-Cidade Universitária, Recife/PE, Brasil.
Lindomar J PenaFundação Oswaldo Cruz-PE/Centro de Pesquisas Aggeu Magalhães, Departamento de Virologia, Campus da UFPE-Cidade Universitária, Recife/PE, Brasil.
Gavin S WilkieMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Ana Da Silva FilipeMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Christopher DavisMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Joseph HughesMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Margus VarjakMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Martin SelingerFaculty of Science, University of South Bohemia, České Budějovice, Czech Republic.
Luíza ZuvanovMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Ania M OwsiankaMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Arvind H PatelMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
John McLauchlanMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Brett D LindenbachDepartment of Microbial Pathogenesis, Yale University, New Haven, Connecticut, United States of America.
Gamou FallPole de Virologie, Unité des arbovirus et virus des fièvres hémorragiques, Institut Pasteur de Dakar, Dakar, Senegal.
Amadou A SallPole de Virologie, Unité des arbovirus et virus des fièvres hémorragiques, Institut Pasteur de Dakar, Dakar, Senegal.
Roman BiekBoyd Orr Centre for Population and Ecosystem Health, Institute of Biodiversity, Animal Health and Comparative Medicine, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom.
Jan RehwinkelMedical Research Council Human Immunology Unit, Weatherall Institute of Molecular Medicine and Radcliffe Department of Medicine, University of Oxford, Oxford, England, United Kingdom.
Esther SchnettlerMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Alain KohlMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
MRC University of Glasgow Centre for Virus Research · GBFundação Oswaldo Cruz · BRInstitut Pasteur de Dakar · SNCzech Academy of Sciences, Biology Centre · CZMRC Human Immunology Unit · GBUniversity of Glasgow · GBYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Medical Research Council G0801822Medical Research Council MC_UU_12010/8Medical Research Council MC_UU_12014/1Medical Research Council MC_UU_12014/12Medical Research Council MC_UU_12014/2Medical Research Council MC_UU_12014/3Medical Research Council MC_UU_12014/8Medical Research Council MR/N017552/1NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

backgroundThe outbreak of Zika virus (ZIKV) in the Americas has transformed a previously obscure mosquito-transmitted arbovirus of the Flaviviridae family into a major public health concern. Little is currently known about the evolution and biology of ZIKV and the factors that contribute to the associated pathogenesis. Determining genomic sequences of clinical viral isolates and characterization of elements within these are an important prerequisite to advance our understanding of viral replicative processes and virus-host interactions. METHODOLOGY/PRINCIPAL

findingsWe obtained a ZIKV isolate from a patient who presented with classical ZIKV-associated symptoms, and used high throughput sequencing and other molecular biology approaches to determine its full genome sequence, including non-coding regions. Genome regions were characterized and compared to the sequences of other isolates where available. Furthermore, we identified a subgenomic flavivirus RNA (sfRNA) in ZIKV-infected cells that has antagonist activity against RIG-I induced type I interferon induction, with a lesser effect on MDA-5 mediated action. CONCLUSIONS/SIGNIFICANCE: The full-length genome sequence including non-coding regions of a South American ZIKV isolate from a patient with classical symptoms will support efforts to develop genetic tools for this virus. Detection of sfRNA that counteracts interferon responses is likely to be important for further understanding of pathogenesis and virus-host interactions.

Indexed as

Genome, ViralA549 CellsAnimalsBrazilDEAD Box Protein 58Disease OutbreaksHigh-Throughput Nucleotide SequencingHost-Pathogen InteractionsHumansInterferon Type IPhylogenyRNA, ViralVero CellsVirus ReplicationZika VirusZika Virus InfectionDEAD Box Protein 58Interferon Type IRNA, Viral

Identifiers

PMID27706161
PMCPMC5051680
OpenAlexW2528427336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.